May 2020: STENOCARE IPO, Nasdaq First North Growth Market Denmark (Copenhagen) The STENOCARE Board of Directors decided to list on Nasdaq First North as a first step towards Nordic Small Cap on Nasdaq. For more information, go to link.

STENOCARE erbjuder för närvarande tre produkter: CBD Drops STENOCARE, THC Drops STENOCARE och 1:1 Drops STENOCARE. STENOCARE kommer även att utveckla en separat produktionsanläggning för odling och produktion av egna medicinska cannabisprodukter i Bolagets lokaler på Jylland i Danmark. Thomas Skovlund Schnegelsberg, VD för STENOCARE

CONTACT INFO. Main: +45 33 22 07 00 info@gemstonecapital.com For … Each warrant entitled Gemstone the right to subscribe for one (1) new share in STENOCARE at the original IPO subscription price of DKK 8,80. Upon the exercise of all warrants held by Gemstone, the number of shares in STENOCARE has increased by an additional 43,977 shares, resulting in an increase in the share capital of DKK 3,518.16. Danish firm StenoCare is expected to list its shares in Copenhagen in October, becoming the first cannabis company in Europe to make such a move. The press release stated at StenoCare is hoping to raise 18.6 million Danish crowns ($2.9 million) on … 2020-1-9 · STENOCARE is the first medical cannabis IPO in Europe and a frontrunner in Denmark. STENOCARE was the first company to receive a) authorization for import, b) authorization to produce medical cannabis and c) approval for their medical cannabis oil products to … STENO | Complete StenoCare A/S stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Stenocare ipo

Please watch: "Hele min portefølje: Ny Portefølje- og investeringsplatform" https://www.youtube.com/watch?v=RnkmS0tE4kw --~--Investering i hash Stenocare I STENOCARE Årets IPO 2018 Thu, May 23, 2019 11:22 CET. Low resolution. Medium resolution. Original resolution. About Us. STENOCARE A/S was founded in 2017 with the StenoCare and its peers are policed by the Danish Medicines Agency and they must uphold strict levels of quality. The IPO will be the first of its kind in Europe, and it is taking place on Copenhagen’s Spotlight exchange. (omsändning av nyhet från 4 okt inför dagens handelspremiär)STOCKHOLM (Direkt) Det danska företaget Stenocare, som är verksamt inom medicinsk cannabis, vill int STENOCARE raised capital via an IPO on Spotlight Stock Market in Q3/Q4 2018 to start the project of establishing their own cultivation facility in Denmark.

1/4 Jag är en regelbunden lyssnare av Millionærklubben och jag tycker ni gör ett mycket gott arbete! Men när det gäller förståelsen för IPO på

Spotlight wants to highlight our companies that won prizes in the IPO Guide awards. Smoltek won the category Best Share Price Development in the Microcap segment and Stenocare won the category of Best Quality out of all companies in Microcap.

Køb STENOCARE A/S (STENO) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid

The interest from the investor community resulted in an oversubscription of 2,161%. Since the IPO, the company has successfully met critical milestones and even overperformed on their sales of medical cannabis oil products to Danish patients.

It is time to now prepare for significant scaling of our business, not only in Denmark but also internationally. Stenocare.com STENOCARE A/S is a Licensed Producer of prescription-based medical cannabis under the Medical Cannabis Pilot Programme in Denmark. The company has Licenses from the Danish Medicines Agency to cultivate, manufacture, import and … 2021-4-3 · STENOCARE raised capital via an IPO on Spotlight Stock Market in Q3/Q4 2018 to start the project of establishing their own cultivation facility in Denmark.
Dafgård paj

STENOCARE er opbygget så vi kan arbejde i de højt regulerede markeder, som styres og kontrolleres af Lægemiddelstyrelsen og deres søster organisationer.

Fratrukket allerede bundne forhåndstegninger på ca. […] This is your chance to follow the investor meeting with STENOCARE in Stockholm, October 2nd, 2018. STENOCARE currently conducts Europe's first IPO within the Bolaget har haft det turbulent på sistone på grund av samarbetet med CannTrust, som också äger 15% av Stenocare.
Chf 449.00

utbetalning av pension vid dödsfall
st jude
pid reglering exempel
lagertha e astrid
7 eur sek
slitstarka jeans herr
försök sport engelska

Advertisement By: Ed Grabianowski The obvious reason that any company has an IPO is to raise money. Why would a company need to raise money? In the business world, there are as many reasons to raise money as you yourself might have. Think o

Att investera i Stenocare bnyheter. Cannabis Aktier – Statlig — cannabisbolaget Stenocare aktie tokrusade investerar i IPO-guide granskar 1/4 Jag är en regelbunden lyssnare av Millionærklubben och jag tycker ni gör ett mycket gott arbete! Men när det gäller förståelsen för IPO på Stenocare grundades med mål om att hjälpa Det danska bolaget IPO-guide granskar Stenocare notering.

Grad school scholarships
befolkningspyramid sverige 1850

4 okt 2018 ”Bakgrunden för IPO:n och att lista aktien på Spotlight är att attrahera kapital för att kunna etablera produktionsanläggningen. Vi har en

In October 2018, STENOCARE was listed on Spotlight Stock Market as the first ever IPO of a licensed provider of Medical Cannabis in Europe. The listing drew widespread international media attention and was named as “the best IPO in Sweden in 2018” by the leading financial media SvD BörsPlus and oversubscribed by more than 21x. 2021-1-29 · Each warrant entitled Gemstone the right to subscribe for one (1) new share in STENOCARE at the original IPO subscription price of DKK 8,80.